Overexpression of Ca2+-permeable AMPA receptor promotes delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia.
To examine the role of Ca(2+) entry through AMPA receptors in the pathogenesis of the ischemia-induced cell death of hippocampal neurons, we delivered cDNA of Q/R site-unedited form (GluR2Q) of AMPA receptor subunit GluR2 in the hippocampus by using an HVJ-liposome-mediated gene transfer technique. Two days prior to transient forebrain ischemia, we injected an HVJ-liposome containing cDNA of the GluR2Q-myc fusion gene into a rat unilateral hippocampus. In the absence of ischemic insult, overexpression of Ca(2+)-permeable GluR2Q did not cause any neurodegeneration in the cDNA-injected hippocampus. In ischemic rats, overexpression of Ca(2+)-permeable GluR2Q markedly promoted ischemic cell death of CA1 pyramidal neurons, while complete rescue of CA1 pyramidal neurons from ischemic damage occurred in the hippocampal hemisphere opposite the GluR2Q expression. Overexpression of the Q/R-site edited form (GluR2R) of subunit GluR2 did not affect the ischemia-induced damage of CA1 pyramidal neurons. From these results, we suggest that the Ca(2+)-permeability of AMPA receptors does not have a direct contribution to glutamate receptor-mediated neurotoxicity but has a promotive action in the evolution of ischemia-induced neurodegeneration of vulnerable neurons.
Division of Brain Science, Kitasato University Graduate School of Medical Sciences, Sagamihara 228-8555, Japan. dm99002@ahs.kitasato-u.ac.jp
Takeshi
T
Anzai
Keisuke
K
Tsuzuki
Nobuaki
N
Yamada
Tomoyo
T
Hayashi
Miwa
M
Iwakuma
Ken
K
Inada
Kimihiko
K
Kameyama
Sumio
S
Hoka
Makoto
M
Saji
D000818:Animals; D002545:Brain Ischemia / Q000503:physiopathology*; D002118:Calcium / Q000378:metabolism*; D016923:Cell Death / Q000502:physiology; D007839:Functional Laterality; D018014:Gene Transfer Techniques; D016259:Genes, myc / Q000502:physiology; D005822:Genetic Vectors; D007150:Immunohistochemistry; D008081:Liposomes; D008297:Male; D009410:Nerve Degeneration / Q000473:pathology / Q000503:physiopathology*; D017966:Pyramidal Cells / Q000378:metabolism / Q000473:pathology*; D051381:Rats; D017208:Rats, Wistar; D018091:Receptors, AMPA / Q000008:administration & dosage / Q000096:biosynthesis*
D008081:Liposomes; D018091:Receptors, AMPA; C104722:glutamate receptor ionotropic, AMPA 2; D002118:Calcium